Show simple item record

dc.creatorOber, Elizabeth Sally Ward
dc.creatorDevanboyina, Venkata Siva Charan
dc.creatorOber, Raimund Johannes
dc.date.accessioned2023-05-03T13:33:43Z
dc.date.available2023-05-03T13:33:43Z
dc.date.issued10/4/2022
dc.identifier.urihttps://hdl.handle.net/1969.1/197564
dc.description.abstractThe present disclosure includes a fusion protein, called a "Seldeg", including a targeting component that specifically binds to a cell surface receptor or other cell surface molecule at near-neutral pH, and an antigen component fused directly or indirectly to the targeting component. The antigen component is configured to specifically bind a target antigen-specific antibody. The present disclosure also includes a method of depleting a target antigen-specific antibody from a patient by administering to the patient a Seldeg having an antigen component configured to specifically bind the target antigen-specific antibody.en
dc.languageEN
dc.publisherUnited States. Patent and Trademark Officeen
dc.rightsPublic Domain (No copyright - United States)en
dc.rights.urihttp://rightsstatements.org/vocab/NoC-US/1.0/
dc.titleFusion Proteins (Seldegs) For Selectively Depleting Antigen-specific Antibodies And Methods Of Use Thereofen
dc.typeUtility patenten
dc.format.digitalOriginreformatted digitalen
dc.description.countryUS
dc.contributor.assigneeTexas A&M University Systemen
dc.identifier.patentapplicationnumber16/465975
dc.date.filed12/1/2017
dc.publisher.digitalTexas A&M University. Libraries
dc.subject.cpcprimaryC07K 16/2881
dc.subject.cpcprimaryC07K 14/71
dc.subject.cpcprimaryC07K 2317/77
dc.subject.cpcprimaryC07K 2317/92
dc.subject.cpcprimaryA61K 38/00
dc.subject.cpcprimaryC07K 2319/30
dc.subject.cpcprimaryC07K 2317/71
dc.subject.cpcprimaryC07K 2317/72
dc.subject.cpcprimaryC07K 2317/52
dc.subject.cpcprimaryA61K 51/1027
dc.subject.cpcprimaryC07K 2317/76
dc.subject.cpcprimaryC07K 2317/569


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record